Pfizer Payout Strains: Income Investors Face Hard Truth
Pfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
Which index fund performed best this year? Review top performers, volatility, and potential shifts to inform your next move.
26,831 articlesPfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
Eli Lilly is delivering big news for investors. The rallying force behind recent gains comes from GLP-1 drugs, manufa...
Lightstone opens access to 25,000+ multifamily units for accredited investors as rents rise in tight markets. The mov...
The CLARITY Act advances toward a Senate floor vote, pledging a single federal regulator for crypto spot markets. But...
Mercadolibre stock down strong after a mixed reaction to solid quarterly results. This article breaks down why growth...
In a shock move, TapTools announced it will wind down operations within 14 days after a wave of leadership departures...
Investors often wonder if buying before a stock split makes sense. This guide explains the mechanics, the CrowdStrike...
Mid-June market data show the Russell 2000 leading the pack, up around 18% year-to-date as small caps take the spotli...
A federal judge blocked the Trump-era SNAP limits on soda and candy, delaying a controversial nutrition policy that w...
NVIDIA CEO Jensen Huang told investors that AI-powered supercomputing could become a common feature in homes within y...
Memory stocks kicked higher Monday, led by SanDisk and Western Digital, as banks turn constructive on the sector. Ana...
Wendy’s faces traffic losses even as it pursues a turnaround with Project Fresh, while McDonald’s leans on loyalty an...